STONE, Jennifer C, Timothy Hugh BARKER, Edoardo AROMATARIS, Merel RITSKES-HOITINGA, Kim SEARS, Miloslav KLUGAR, Jo LEONARDI-BEE and Zachary MUNN. From critical appraisal to risk of bias assessment: clarifying the terminology for study evaluation in JBI systematic reviews. JBI Evidence Synthesis. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS, 2023, vol. 21, No 3, p. 472-477. ISSN 2689-8381. Available from: https://dx.doi.org/10.11124/JBIES-22-00434.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name From critical appraisal to risk of bias assessment: clarifying the terminology for study evaluation in JBI systematic reviews
Authors STONE, Jennifer C (guarantor), Timothy Hugh BARKER, Edoardo AROMATARIS, Merel RITSKES-HOITINGA, Kim SEARS, Miloslav KLUGAR (203 Czech Republic, belonging to the institution), Jo LEONARDI-BEE and Zachary MUNN.
Edition JBI Evidence Synthesis, PHILADELPHIA, LIPPINCOTT WILLIAMS & WILKINS, 2023, 2689-8381.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30230 Other clinical medicine subjects
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.700 in 2022
RIV identification code RIV/00216224:14110/23:00130600
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.11124/JBIES-22-00434
UT WoS 000945987900003
Keywords in English critical appraisal; methodology; quality; risk of bias; systematic review
Tags 14119612, 14119613, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 17/4/2023 10:37.
Abstract
The foundations for critical appraisal of literature have largely progressed through the development of epidemiologic research methods and the use of research to inform medical teaching and practice. This practical application of research is referred to as evidence-based medicine and has delivered a standard for the health care profession where clinicians are equally as engaged in conducting scientific research as they are in the practice of delivering treatments. Evidence-based medicine, now referred to as evidence-based health care, has generally been operationalized through empirically supported treatments, whereby the choice of treatments is substantiated by scientific support, usually by means of an evidence synthesis. As evidence synthesis methodology has advanced, guidance for the critical appraisal of primary research has emphasized a distinction from the assessment of internal validity required for synthesized research. This assessment is conceptualized and branded in various ways in the literature, such as risk of bias, critical appraisal, study validity, methodological quality, and methodological limitations. This paper provides a discussion of the definitions and characteristics of these terms, concluding with a recommendation for JBI to adopt the term “risk of bias” assessment.
Links
LTC20031, research and development projectName: Towards an International Network for Evidence-based Research in Clinical Health Research in the Czech Republic
Investor: Ministry of Education, Youth and Sports of the CR, INTER-COST
PrintDisplayed: 28/7/2024 02:17